Skip to main content
Premium Trial:

Request an Annual Quote

LexaGene Reports $58K in Fiscal Q4 Revenues, Spurred by MiQLab Launch

NEW YORK – Pathogen diagnostics firm LexaGene said on Monday that its revenue for the fourth quarter of fiscal year 2020 was $58,125, driven by the initial launch of its PCR-based MiQLab system in December 2020. The company did not report any revenue during the same quarter a year ago.

The Beverly, Massachusetts-based firm noted that all revenue from the quarter ended Feb. 28 was generated from US customers, through sales of two MiQLab systems and consumables.

LexaGene aims to differentiate itself from competitors with its MiQLab sample-to-answer RT-PCR system that it believes can be adapted to different communities and demands during the pandemic.

The company had a net loss of $2.4 million, or $0.03 per share, in Q4 versus a net loss of $1.7 million, or $0.03 per share, in the year-ago quarter.

R&D expenses in Q4 were $1.4 million, up 40 percent from $1.0 million last year, while SG&A expenses increased 24 percent to $822,000 from $665,000 in the year-ago period.

For full fiscal year 2020, LexaGene's net loss was $9.9 million, or $0.10 per share, compared to $7.5 million, or $.10 per share, a year ago.

Research expenses for the year were $5.8 million, up 29 percent from $4.5 million last year. Meanwhile, sales, marketing, general, and administrative expenses rose 33 percent to $4.0 million from $3.0 million.

LexaGene ended the fiscal year with $9.6 million in cash.

Earlier this month, LexaGene partnered with Denver-based Ethos Discovery to expand test menu offerings on LexaGene's MiQLab pathogen detection system.

In afternoon trading on the OTCQB, LexaGene shares were down 15 percent at $0.50.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.